Gene Therapy
Innovative Trends That Drive AAV Capture and Empty-Full Separation
Ratish Krishnan and Oliver Rammo share their thoughts on the need for a more nuanced understanding of AAV…
Oliver Rammo
Oliver Rammo is leading the Novel Modality segment in the Purification R&D Group responsible for the development of novel purification strategies for the Viral and Gene Therapy market. Prior to his current role, he worked as Laboratory Manager and Application Engineer for the MilliporeSigma Life Science division. He joined
Merck KGaA, Darmstadt, Germany
MilliporeSigma
in 2012, working for Performance Materials Advanced Technologies in the field of printing formulations for photovoltaic applications. Oliver holds a BSc in Applied Life Science from the University of Kaiserslautern and an MSc in Molecular Biotechnology from the University of Frankfurt.
